Document 0427
 DOCN  M9460427
 TI    Menstrual symptoms in women infected by the human immunodeficiency
       virus.
 DT    9404
 AU    Shah PN; Smith JR; Wells C; Barton SE; Kitchen VS; Steer PJ; Department
       of Obstetrics and Gynaecology, Charing Cross and; Westminster Medical
       School, London, United Kingdom.
 SO    Obstet Gynecol. 1994 Mar;83(3):397-400. Unique Identifier : AIDSLINE
       MED/94173528
 AB    OBJECTIVE: To determine whether there is a higher prevalence of
       menstrual symptoms in women seropositive for the human immunodeficiency
       virus (HIV) compared to a matched control group and to examine the
       relation between menstrual symptomatology and immunosuppression.
       METHODS: In a cross-sectional study, 55 HIV-seropositive women and a
       matched control group underwent detailed gynecologic assessment. The
       prevalence of regular cycles, oligomenorrhea, amenorrhea, menorrhagia,
       dysmenorrhea, and dyspareunia was assessed in the two groups. Any
       association with clinical disease or CD4 lymphocyte count was sought.
       RESULTS: There were no significant differences in the prevalence of
       oligomenorrhea, amenorrhea, menorrhagia, dysmenorrhea, or dyspareunia
       between the groups. Furthermore, no differences were demonstrated
       between symptomatic and asymptomatic women infected by HIV, nor was any
       correlation found between CD4 lymphocyte count and menstrual loss or
       dysmenorrhea. CONCLUSION: Infection with HIV and related
       immunosuppression do not seem to have a clinically significant effect on
       menstruation.
 DE    Adult  Cross-Sectional Studies  Female  Human  HIV
       Seropositivity/*COMPLICATIONS  Menstruation
       Disorders/EPIDEMIOLOGY/*ETIOLOGY  Middle Age  Prevalence  Support,
       Non-U.S. Gov't  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).